EUDA Health Holdings Limited (NasdaqCM:EUDA) signed a letter of intent to acquire TheoremRx Inc. on October 4, 2023. Under the letter of intent, TheoremRx would merge with a subsidiary of EUDA. The transaction is subject to the negotiation of a definitive agreement, regulatory approvals, and the satisfaction of customary closing conditions.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.65 USD | -3.64% | +13.25% | +85.31% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+85.31% | 95.23M | |
+4.15% | 32.82B | |
+20.93% | 7.95B | |
+29.70% | 4.39B | |
-35.00% | 2.65B | |
-15.47% | 1.49B | |
-10.39% | 1.48B | |
-37.85% | 1.12B | |
+8.26% | 994M | |
-40.15% | 840M |
- Stock Market
- Equities
- EUDA Stock
- News EUDA Health Holdings Limited
- EUDA Health Holdings Limited signed a letter of intent to acquire TheoremRx Inc.